SCHEMBL106302

SCHEMBL106302

C/C=C\c1cc(C(=O)O)ccc1N1C[C@H](C)N(C(=O)OC(C)(C)C)C[C@H]1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.40
SETD7 Q8WTS6 2/20 0.36
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
NR4A1 P22736 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAP4K4 O95819 1/20 0.33
HDAC1 Q13547 1/20 0.33
SMARCA2 P51531 1/20 0.33
SMARCA4 P51532 1/20 0.33
PBRM1 Q86U86 1/20 0.33
USP30 Q70CQ3 4/20 0.32
UCHL1 P09936 1/20 0.32
NPC1 O15118 1/20 0.31
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL105834 1.00 GPR119 (0.40) GPR119SETD7KDM4EPOLBGAA
SCHEMBL106303 1.00 GPR119 (0.40) GPR119SETD7KDM4EPOLBGAA
SCHEMBL105835 1.00 GPR119 (0.40) GPR119SETD7KDM4EPOLBGAA
SCHEMBL105832 1.00 GPR119 (0.40) GPR119SETD7KDM4EPOLBGAA
SCHEMBL105833 1.00 GPR119 (0.40) GPR119SETD7KDM4EPOLBGAA
SCHEMBL16549836 0.90 GPR119 (0.39) GPR119SETD7KDM4EHSD17B10MAP4K4
SCHEMBL16549837 0.90 GPR119 (0.39) GPR119SETD7KDM4EHSD17B10MAP4K4
SCHEMBL135246 0.85 SMARCA2 (0.47) GPR119SETD7SMARCA2SMARCA4PBRM1
SCHEMBL135247 0.85 SMARCA2 (0.47) GPR119SETD7SMARCA2SMARCA4PBRM1
SCHEMBL135248 0.85 SMARCA2 (0.47) GPR119SETD7SMARCA2SMARCA4PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426113-B1 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER KOWA CO (JP) 2013-11-06 EP disclosed
US-8551985-B2 Carbinol derivatives having heterocyclic linker KOWA COMPANY, LTD. (JP) 2013-10-08 US disclosed
EP-2426113-A1 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER Kowa Company, Ltd. (JP) 2012-03-07 EP disclosed
US-20100280013-A1 CARBINOL DERIVATIVES HAVING HETEROCYCLIC LINKER KOWA COMPANY, LTD. (JP) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280013-A1 CARBINOL DERIVATIVES HAVING HETEROCYCLIC LINKER NR1H2, NR1H3, CCR2 GPR119 16/4885SETD7 2477/4885KDM4E 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.